Allogene Therapeutics, Inc.

NASDAQ:ALLO

1.15 (USD) • At close September 5, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 000000.0220.0210.0220.0220.030.0470.0490.0860.0610.0510.0490.04438.3450000000000000
Kosten van de omzet 3.1063.0993.2333.2073.6443.5553.4773.57200000000000000000000000
Brutowinst -3.106-3.099-3.233-3.207-3.644-3.533-0.044-3.550.0220.030.0470.0490.0860.0610.0510.0490.04438.3450000000000000
Brutowinstmarge 00000-160.591-2.095-161.36411111111110000000000000
Onderzoek- en ontwikkelingskosten 40.15650.244.97244.71350.35552.25954.66145.97762.03880.23875.41963.64157.17160.15653.98358.7252.2955.18352.22851.42147.29642.04249.36339.99531.77423.40318.50410.87122.48600
Algemene en administratieve kosten 14.28114.99115.51816.33316.08717.26717.22417.04118.52418.88421.00218.89719.50919.89719.96118.99918.78316.36317.13416.61915.86215.64115.21215.01614.18713.05814.54211.31712.5262.5970
Verkoop- en marketingkosten 0000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 14.28114.99115.51816.33316.08717.26717.22417.04118.52418.88421.00218.89719.50919.89719.96118.99918.78316.36317.13416.61915.86215.64115.21215.01614.18713.05814.54211.31712.5262.5970.002
Overige kosten -3.106-3.099-3.233-33.985-45.366-3.55513.245-3.57200000000000000000000000
Bedrijfskosten 51.33162.09257.25727.06121.07665.97185.1359.44680.56299.12296.42182.53876.6880.05373.94477.71971.07371.54669.36268.0463.15857.68364.57555.01145.96136.46133.04622.187135.0122.5970.002
Bedrijfsresultaat -56.819-65.191-60.49-71.774-71.431-69.504-85.174-62.996-80.54-99.092-96.374-82.489-76.594-79.992-73.893-77.67-71.029-33.201-69.362-68.04-63.158-57.683-64.575-55.011-45.961-36.461-33.046-22.187-135.012-2.597-0.002
Bedrijfsresultaat ratio 00000-3,159.273-4,055.905-2,863.455-3,660.909-3,303.067-2,050.511-1,683.449-890.628-1,311.344-1,448.882-1,585.102-1,614.295-0.8660000000000000
Totaal overige inkomsten en kosten netto 5.8765.4580.9945.4815.0734.504-4.0830.7091.308-0.8761.527-0.6591.8070.142-0.975-0.5160.0930.1860.7921.8432.1843.2033.394.3094.5594.8252.42-21.310.1100
Inkomen voor belasting -50.943-59.733-59.496-66.293-66.358-65-89.257-62.287-79.232-99.968-94.847-83.148-74.787-79.85-74.868-78.186-70.936-33.015-68.57-66.197-60.974-54.48-61.185-50.702-41.402-31.636-30.626-43.497-134.902-2.597-0.002
Inkomen voor belasting ratio 00000-2,954.545-4,250.333-2,831.227-3,601.455-3,332.267-2,018.021-1,696.898-869.616-1,309.016-1,468-1,595.633-1,612.182-0.8610000000000000
Belastingkosten 000.4430000000000000000000-0.1550.033-0.159-0.0500000
Nettowinst -50.943-59.733-59.939-66.293-66.358-65-89.623-62.287-79.232-99.968-94.847-83.148-74.787-79.85-74.868-78.186-70.936-33.015-68.57-66.197-60.974-54.48-61.03-50.735-41.243-31.586-30.509-43.497-134.902-2.597-0.002
Nettowinstmarge 00000-2,954.545-4,267.762-2,831.227-3,601.455-3,332.267-2,018.021-1,696.898-869.616-1,309.016-1,468-1,595.633-1,612.182-0.8610000000000000
WPA (Winst Per Aandeel) -0.23-0.28-0.28-0.32-0.35-0.38-0.51-0.37-0.54-0.68-0.66-0.58-0.52-0.56-0.54-0.57-0.53-0.25-0.53-0.52-0.53-0.5-0.58-0.5-0.41-0.32-0.37-0.38-1.19-0.059-0
Verwaterde WPA -0.23-0.28-0.28-0.32-0.35-0.38-0.51-0.37-0.54-0.68-0.66-0.58-0.52-0.56-0.54-0.57-0.53-0.25-0.53-0.52-0.53-0.5-0.58-0.5-0.41-0.32-0.37-0.38-1.19-0.059-0
EBITDA -56.819-56.484-56.182-62.986-62.798-61.445-68.452-58.715-76.897-95.585-93.306-78.629-72.919-76.3-69.651-75.34-69.065-31.283-59.496-66.23-61.27-55.639-59.33-53.683-44.812-35.766-30.079-39.636-134.562-2.597-0.002
EBITDA ratio 00000-2,792.955-3,259.619-2,668.864-3,495.318-3,186.167-1,985.234-1,604.673-847.895-1,250.82-1,365.706-1,537.551-1,569.659-0.8160000000000000